1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Zhangzhou Pientzehuang Pharmaceutical., Ltd
  6. Summary
    600436   CNE000001F21

ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD

(600436)
  Report
End-of-day quote Shanghai Stock Exchange  -  2022-07-05
345.01 CNY   -1.89%
04/22Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/15Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
CI
2021Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
06/30/2022 07/01/2022 07/04/2022 07/05/2022 07/06/2022 Date
356.73 350.78 353.44 351.66 345.01 Last
2825453 1907806 2071383 2517818 2286795 Volume
+2.21% -1.67% +0.76% -0.50% -1.89% Change
Estimated financial data (e)
Sales 2022 9 494 M 1 415 M 1 415 M
Net income 2022 3 031 M 452 M 452 M
Net cash position 2022 8 984 M 1 339 M 1 339 M
P/E ratio 2022 69,1x
Yield 2022 0,41%
Sales 2023 11 103 M 1 655 M 1 655 M
Net income 2023 3 736 M 557 M 557 M
Net cash position 2023 10 540 M 1 571 M 1 571 M
P/E ratio 2023 56,1x
Yield 2023 0,50%
Capitalization 208 B 31 031 M 31 031 M
EV / Sales 2022 21,0x
EV / Sales 2023 17,8x
Nbr of Employees 2 591
Free-Float 38,1%
More Financials
Company
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL.LTD is a China-based company principally engaged in pharmaceutical production and distribution business. The Company's major products include Pientzehuang series for pain-inhibition, anti-inflammation, detoxification and curing hepatitis, tablets for coronary heart diseases and hypertension, bupleurum granules for cold, as well as pharmaceuticals for bone injuries and others.... 
Sector
Pharmaceuticals
Calendar
08/22Earnings Release
More about the company
Ratings of Zhangzhou Pientzehuang Pharmaceutical., Ltd
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
04/22Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quar..
CI
04/15Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Full Year ..
CI
2021Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Month..
CI
2021MARKET CHATTER : Century-Old Chinese Companies Tap Into Stock Market to Fuel Growth
MT
2021Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year ..
CI
2021Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quar..
CI
2021EXCLUSIVE : Sinopharm-led consortium plans $3.3 billion take-private of HK-listed China TC..
RE
2020Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Month..
CI
2020China stocks end lower as high-flying consumer shares retreat
RE
2020Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year ..
CI
2020Zhangzhou Pientzehuang Pharmaceutical., Ltd Approves Proposal of Investing in Newly Est..
CI
2020Longhui Pharmaceutical Co., Ltd. announced that it expects to receive CNY 44.4759 milli..
CI
2020Zhangzhou Pientzehuang Pharmaceutical., Ltd agreed to acquire 29.2% stake in Longhui Ph..
CI
2020Zhangzhou Pientzehuang Pharmaceutical., Ltd Announces Cash Dividend Per A Share for the..
CI
2020Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Full Year ..
CI
More news
News in other languages on ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
04/22Zhangzhou Pientzehuang Pharmaceutical., Ltd annonce ses résultats pour le premier trime..
04/15Zhangzhou Pientzehuang Pharmaceutical., Ltd annonce ses résultats pour l'année complète..
2021EXCLUSIF : Un consortium dirigé par Sinopharm envisage de privatiser China TCM, cotée à HK..
2020Borsa Shanghai in calo, pesano titoli legati al consumo
2020Zhangzhou Pientzehuang Pharmaceutical, Ltd. annonce un dividende en espèces par action ..
More news
Chart ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
Duration : Period :
Zhangzhou Pientzehuang Pharmaceutical., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 345,01 CNY
Average target price 356,76 CNY
Spread / Average Target 3,41%
EPS Revisions
Managers and Directors
Dong Ming Hong Chairman-Supervisory Board
Wei Qi Lin Chairman
Jian Jun Jia Independent Director
Guang Pei Li Independent Director
Zhi Peng Fan Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD-21.08%31 577
JOHNSON & JOHNSON4.13%468 758
ELI LILLY AND COMPANY19.52%294 514
PFIZER, INC.-12.55%289 747
ABBVIE INC.13.69%272 011
ROCHE HOLDING AG-15.85%269 131